EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction

Riccardo Farinella, Alessio Felici, Giulia Peduzzi, Sabrina Gloria Giulia Testoni, Eithne Costello, Paolo Aretini, Ricardo Blazquez-Encinas, Elif Oz, Aldo Pastore, Matteo Tacelli, Burçak Otlu, Daniele Campa und 1 weitere

Seminars in Cancer Biology · 2025

DOI: 10.1016/j.semcancer.2025.03.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025. Verfasst von Riccardo Farinella und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Artificial Intelligence, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Commission, European Cooperation in Science and Technology, Pancreatic Cancer UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the most lethal malignancies, characterized by late-stage diagnosis and limited therapeutic options. Risk stratification has traditionally been performed using epidemiological studies and genetic analyses, through which key risk factors, including smoking, diabetes, chronic pancreatitis, and inherited predispositions, have been identified. However, the multifactorial nature of PDAC has often been insufficiently addressed by these methods, leading to limited precision in individualized risk assessments. Advances in artificial intelligence (AI) have been proposed as a transformative approach, allowing the integration of diverse datasets-spanning genetic, clinical, lifestyle, and imaging data into dynamic models capable of uncovering novel interactions and risk profiles. In this review, the evolution of PDAC risk stratification is explored, with classical epidemiological frameworks compared to AI-driven methodologies. Genetic insights, including genome-wide association studies and polygenic risk scores, are discussed, alongside AI models such as machine learning, radiomics, and deep learning. Strengths and limitations of these approaches are evaluated, with challenges in clinical translation, such as data scarcity, model interpretability, and external validation, addressed. Finally, future directions are proposed for combining classical and AI-driven methodologies to develop scalable, personalized predictive tools for PDAC, with the goal of improving early detection and patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceCarcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansRisk AssessmentRisk FactorsMachine LearningGenome-Wide Association StudyGenetic Predisposition to Disease

Stichwörter der Autor:innen

Artificial intelligenceEarly detectionGenetic susceptibilityPancreatic cancerRisk stratification

Autor:innen und Institutionen

  • Department of Biology, University of Pisa, Pisa, Italy.
  • Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Policlinico San Donato, Vita-Salute San Raffaele University, Milan, Italy.
  • Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool, United Kingdom.
  • Fondazione Pisana per la Scienza, San Giuliano Terme, Italy.
  • Department of Cell Biology, Physiology and Immunology, University of Cordoba / Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
  • Department of Biostatistics and Bioinformatics, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.

Förderung

  • European Commission
  • European Cooperation in Science and Technology
  • Pancreatic Cancer UK
  • Middle East Technical University
  • Cancer Research UK

Zitieren

APA

Farinella, R., Felici, A., Peduzzi, G., Testoni, S. G. G., Costello, E., Aretini, P., Blazquez-Encinas, R., Oz, E., Pastore, A., Tacelli, M., Otlu, B., Campa, D., & Gentiluomo, M. (2025). From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.03.004

Vancouver

Farinella R, Felici A, Peduzzi G, Testoni SGG, Costello E, Aretini P, et al. From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2025.03.004

BibTeX
@article{Farinella2025,
  author = {Farinella, Riccardo and Felici, Alessio and Peduzzi, Giulia and Testoni, Sabrina Gloria Giulia and Costello, Eithne and Aretini, Paolo and Blazquez-Encinas, Ricardo and Oz, Elif and Pastore, Aldo and Tacelli, Matteo and Otlu, Burçak and Campa, Daniele and Gentiluomo, Manuel},
  title = {From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction},
  journal = {Seminars in Cancer Biology},
  year = {2025},
  doi = {10.1016/j.semcancer.2025.03.004}
}
Kostenlos starten →